0
Détail d'une collection
|
Documents disponibles dans la collection (3)


Titre : E-cigarette-associated acute severe asthma in a smoking-naïve adolescent : a case report Type de document : document électronique Auteurs : Lucas Küppers, Auteur Editeur : Springer Nature Année de publication : 2024 Collection : Cureus, ISSN 2168-8184 num. 16(8) Importance : p. 1-5 Présentation : graph.; tab Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] prévention:santé
[TABAC] tabagisme:pathologie:cancer
[TABAC] tabagisme:pathologie:pathologie cardio-vasculaire
[TABAC] tabagisme:pathologie:pathologie respiratoire:asthme
[TABAC] tabagisme:risque
[TABAC] tabagisme:tabagisme actif:tabagisme adolescentIndex. décimale : TA 2.4.1 Enfants et jeunes Résumé : Electronic cigarettes (e-cigarettes) have become a prevalent phenomenon among adolescents and young adults, particularly as a perceived less harmful alternative to traditional tobacco cigarettes. A number of potential health risks associated with e-cigarettes have been identified, including links to cardiovascular diseases, asthma, and cancer. Given that adolescents have not yet completed their physical development, they are particularly susceptible to adverse health effects associated with e-cigarettes. This case report details the presentation of a healthy 16-year-old female patient who developed her first episode of acute severe asthma and a concomitant lower respiratory tract infection in a primary care practice setting. Prior to the onset of her symptoms, the smoking-naïve patient intermittently shared a nicotine-containing e cigarette with a friend over a three-day period. Following outpatient treatment with inhaled corticosteroids, beta-2 agonists, and antibiotics, the asthma and lower respiratory tract infection were found to be reversible within the first week of treatment initiation. It is imperative that preventive measures at the political level be implemented to counteract the appeal and use of e-cigarettes among adolescents. En ligne : https://www.doi.org/10.7759/cureus.67422 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10473 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : A scoping review of behavioural studies on heated tobacco products Type de document : document électronique Auteurs : Ian M. Fearon, Auteur ; Sarah F. Codery, Auteur ; Martin Fitzpatrick, Auteur Editeur : Springer Nature Année de publication : 2024 Collection : Cureus, ISSN 2168-8184 num. 16(7) Importance : p. 1-37 Présentation : ill. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] chimie du tabac:tabac non fumé:tabac chauffé
[TABAC] étude
[TABAC] sevrage tabagique
[TABAC] tabagisme:aspect psychologique:comportement
[TABAC] tabagisme:risqueIndex. décimale : TA 4.1 Habitudes tabagiques Résumé : Heated tobacco products (HTPs) are electronic devices that heat tobacco sticks to temperatures much lower than those which cause pyrolysis and combustion in cigarettes. While this electrical heating causes the formation of an inhalable aerosol which contains nicotine, the aerosol from HTPs contains significantly fewer and lower levels of the harmful and potentially harmful chemicals found in cigarette smoke. As a result, HTP use potentially conveys reduced risks to health compared to cigarette smoking. While this relative reduction in individual health risk is becoming clearer, what is less certain is the impact of HTPs on overall population‑level health, taking into account both the potential positive impact on adult smokers who completely switch to using HTPs and any unintended impacts such as use by tobacco non‑users and particularly by youth. The aim of this scoping review was to collate and evaluate the published scientific evidence to date, with a cut‑off of 1 January 2024, investigating the impact of HTPs on population‑level health. This evaluation suggests that HTP use is almost exclusively observed among those with a history of cigarette smoking, and there is a growing body of evidence for the ability of HTPs to provide support for adult smokers to transition away from cigarette smoking, in the absence of any significant “gateway” into tobacco use initiation. Many studies have reported a significant degree of dual use of cigarettes and HTPs, and efforts to assess the reasons for such patterns of use, whether these provide overall exposure reductions, and whether dual use acts as a bridge towards a complete transition away from cigarette smoking, requires further investigation. In addition, correction of the widespread and increasing misperceptions of HTPs among adult smokers is recommended to promote HTP uptake as a potentially less harmful alternative to smoking in this population. En ligne : https://doi.org/10.7759/cureus.65773 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10497 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Tobacco-free nicotine pouches and their potential contribution to tobacco harm reduction / Erika Grandolfo (2024)
![]()
Titre : Tobacco-free nicotine pouches and their potential contribution to tobacco harm reduction : a scoping review Type de document : document électronique Auteurs : Erika Grandolfo, Auteur ; Henry Ogden, Auteur ; Ian M. Fearon, Auteur Editeur : Springer Nature Année de publication : 2024 Collection : Cureus, ISSN 2168-8184 num. 16(2) Importance : p. 1-27 Présentation : ill., graph.; tab. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] prévention:stratégie:réduction du risque
[TABAC] sevrage tabagiqueMots-clés : Pouche de nicotine Index. décimale : TA 5.8 Réduction des risques Résumé : Tobacco harm reduction (THR) refers to strategies designed to reduce the health risks associated with tobacco smoking but may involve continued use of nicotine and/or tobacco. Next-generation products (NGPs) are a THR alternative as they do not burn tobacco or produce smoke and deliver nicotine and have fewer and substantially lower levels of harmful chemicals compared to cigarettes. Tobacco‑free nicotine pouches (TFNPs) are an emerging category of nicotine‑containing oral products that do not combust or contain tobacco leaf. Similar to Swedish snus, TFNPs are placed between a user’s lip and gum, and nicotine is absorbed through the oral mucosa rather than being inhaled. The aim of this scoping review was to systematically collate and evaluate published scientific evidence (cut‑off of 31 May 2023) identified from bibliometric databases investigating the potential of TFNPs to contribute to THR. Overall, studies examining chemical constituents indicated that the use of TFNPs may result in lower exposure to toxicants than other tobacco or nicotine-containing products, both combustible and non‑combustible. This reduction in toxicant exposure has been demonstrated by multiple human biomarker studies and in vitro toxicological assessments to translate to harm reduction potential in smokers switching to TFNPs. However, further study is warranted. At present, there is some evidence from human behavioral research that TFNPs can support either transitioning away from smoking or reducing cigarette consumption. Furthermore, TFNP use appears very much limited to current users of traditional tobacco products, and youth uptake has been limited. In conclusion, the findings of this review indicate that TFNPs have the potential to support THR efforts and may help inform evidence‑based regulation. En ligne : https://doi.org/10.7759/cureus.54228 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10532 Aucun avis, veuillez vous identifier pour ajouter le vôtre !